Allergan plc (AGN) is set to report its fourth-quarter 2018 earnings results on Tuesday, January 29, before market open. Analysts expect earnings to drop 14% year-over-year to $4.15 per share. Revenue is expected to decrease 8% to $3.9 billion. The company has consistently reported better-than-expected earnings over the past four quarters and can be expected … Continue reading Earnings preview: Botox to drive Allergan’s growth in Q4